Mass General Hospital

Harvard Medical School

Hummingbird Study: a new medication treatment study for postpartum depression

 

Anxious. Sad. Crying a lot. These are symptoms of postpartum depression. The Hummingbird Study is a research study evaluating an investigational medication in women suffering from moderate to severe postpartum depression.

You may qualify to participate in this study if you are between 18 to 45 years old, gave birth within the last 6 months, and feel extremely sad, anxious, or overwhelmed frequently as these symptoms are associated with postpartum depression.

If you qualify and decide to participate, you will receive 24-hour care and support for your postpartum depression during the 3-day, in-patient period. All study-related medical care and medication provided at no cost.

 This study is being conducted through the Center for Women’s Mental Health at the Massachusetts General Hospital in Boston.  For more information, please visit this page, or call Lauren at 617-724-1181 or email lclaypoole@partners.org.